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This issue’s Molecular Biology Select highlights recent studies that further the understanding of how chromatin structure
is regulated andmaintained in a variety of different biological contexts to ensure theprecise regulation of gene expression.
Two of the studies report noncoding RNAs, which are cofactors that direct proteins to modulate chromatin structure. The
other three studies delve into the roles played by chromatin in the prevention of autoimmunity and the establishment of
gene repression during cellular differentiation, as well as how chromatin marks may be maintained during cell division.
The Shadow Regulator behind Xist
In female mammals, one of the two X chromosomes is transcriptionally silenced to ensure equal dosage of
X-linked genes between the two sexes. This process, known as X-chromosome inactivation (XCI), requires
the expression and spread of the Xist noncoding RNA (ncRNA) over one of the X chromosomes to induce
a cascade of chromatin changes that ultimately result in transcriptional repression. Zhao et al. (2008)
now identify an ncRNA within the Xist coding region that mediates recruitment of the Polycomb Repressive
Complex 2 (PRC2) chromatin regulatory complex to direct these crucial alterations to the future inactive X
chromosome. Histone H3 lysine 27 methylation (H3K27me) on the future inactive X chromosome has been
thought to be necessary for the induction of Xist transcription. RNA immunoprecipitation from both pre-XCI
mouse embryonic stem cells and post-XCI mouse embryonic fibroblasts (MEFs) showed an association
between the H3K27methylase PRC2 and the A-repeat region of the Xist transcript. Surprisingly, the authors
found that the A-repeat region encodes a smaller ncRNA that directly interacts with PRC2 components
in vitro and is sufficient to recruit PRC2 to ectopic sites in vivo when expressed from autosomes. Depletion
of this ncRNA called RepA or of PRC2 components compromised the induction of Xist expression and
hence the establishment of XCI, indicating that RepA-mediated recruitment of PRC2 is essential to this
process. Interestingly, the authors observed that the antisense Xist transcript, Tsix, which acts as a Xist
antagonist and maintains the active X chromosome, can compete with RepA for binding to PRC2 compo-
nents in vitro. This suggests the intriguing possibility that the timing of RepA-mediated XCI is modulated by
Tsix expression and repression on the future inactive X chromosome.
J. Zhao et al. (2008). Science 322, 750–756.
Treading an ncRNA Path to Silencing
The Kcnq1ot1 noncoding RNA (ncRNA) is a long, antisense transcript that has been
linked to the silencing of a 1 Mb domain (Kcnq1 domain) on the paternal chromosome
in mammals. Pandey et al. (2008) now establish a direct role for the Kcnq1ot1 ncRNA
in the recruitment of chromatin-modifying factors that function in the Kcnq1 domain to di-
rect lineage-specific imprinted transcriptional silencing. Previous studies demonstrated
that gene expression within theKcnq1 domain differed between placental and embryonic
tissues in mice, with more genes being transcriptionally silenced in the placental tissue.
Consistent with this, the authors uncovered a difference in Kcnq1ot1 association with
chromatin betweenmouse placental and liver tissues. A combination of chromatin immu-
noprecipitation and RNA immunoprecipitation revealed that despite increased expres-
sion of Kcnq1ot1 RNA in the liver, more Kcnq1ot1 associates with chromatin in placental
tissue. Further analysis of Kcnq1ot1 chromatin binding in placental tissue revealed that
Kcnq1ot1 ncRNA specifically associates with imprinted, transcriptionally silenced genes
in the Kcnq1 domain. Interestingly, disruption of Kcnq1ot1 expression in mice by deleting
the Kcnq1ot1 promoter region resulted in the loss of placental-specific regions of histone
H3 lysine 27 trimethylation (H3K27me3), a heterochromatic histone modification associated with transcriptional repression. This
suggested that Kcnq1ot1 may function at these sites to recruit chromatin-modifying factors to mediate gene silencing. Indeed,
RNA immunoprecipitation experiments demonstrated that theKcnq1ot1RNA interacts with components from both the H3K27meth-
yltransferase Polycomb Repressive Complex 2 and the G9a methyltransferase responsible for methylation of histone H3 lysine 9,
another repressivemark enriched at silenced placental genes. Taken together, these findings strongly implicate theKcnq1ot1 ncRNA
as the mediator of lineage-specific transcriptional silencing. The molecular identities of the tissue-specific factors that underlie the
differential association of the Kcnq1ot1 ncRNA in placental versus embryonic tissues remain an interesting area of future study.
R.R. Pandey et al. (2008). Mol. Cell 32, 232–246.
Histone H3 Puts on Aires
Expression of the transcriptional activator Aire in the medullary epithelial cells of the thymus is crucial for presentation of peripheral
tissue antigens in the thymus, a process that promotes immunological self-tolerance. Koh et al. (2008) nowuncover evidence suggest-
ing that Aire directs ectopic expression of peripheral tissue-specific genes normally repressed in the thymus by directly binding to
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chromatin. TheAire protein harbors twoPHDfinger domains, structures that are known
to bind to specific modifications on histone N-terminal tails. By assaying the ability of
the two PHD finger domains from the murine Aire protein to bind alone or together to
an array of60 different modified and unmodified histone peptides in vitro, the authors
determined that the first PHD finger domain, PHD1,mediates binding to histones. Spe-
cifically, PHD1 associates with the first nine amino acids of the unmodified histone H3
tail and can beprevented frombinding if the histone tail is dimethylated or trimethylated
on lysine 4 (K4). Interestingly, two point mutations in the Aire protein (C313Y and
P238L), which are associated with the human disease APECED (autoimmune polyen-
docrinopathy-candidiases-ectodermal dystrophy), both disrupt binding of Aire to the
H3 tail. This suggests that binding to H3 is necessary for Aire function. Indeed, Koh
and colleagues found that in two cultured human cell lines that model Aire-mediated
peripheral tissue antigen expression, binding to the histone H3 tail is required for Aire’s
association with chromatin. Abrogation of Aire’s H3 association through mutation or
deletion of the PHD1 domain disrupted transcriptional upregulation of three genes encoding peripheral tissue antigens. Aire proteins
are known tobe located in puncta near nuclear speckles that harbor factors essential for transcriptional activation. Thus, thenewstudy
suggests that H3 binding by Aire may allow both the formation of chromatin domains containing specific genes encoding peripheral
tissue antigens and the targeting of these domains to nuclear speckles for gene expression in the thymus. In this manner, Aire can
directly mediate the expression of antigens that limit self-reactivity in the immune system.
A.S. Koh et al. (2008). Proc. Natl. Acad. Sci. USA 105, 15878–15883.
The Permanence of Sin(3)
The Sin3 corepressor protein is a component of poorly characterized complexes that regulate gene expression through multiple
histone-modification and chromatin-remodeling activities. van Oevelen et al. (2008) now uncover a role for Sin3 in directing the chro-
matin changes necessary for the permanent repression of cell-cycle genes during the terminal differentiation of skeletal muscle cells.
By mapping Sin3 binding throughout the mouse genome in differentiated muscle cells (myotubes) using ChIP-on-chip and compar-
ing the results to the binding pattern of the cell-cycle gene expression regulator E2F4, the authors identified a subset of genes that
were bound by both proteins downstream of the transcriptional start site. Interestingly, Sin3 and E2F4 display overlapping binding
profiles and patterns of distribution at this subset of genes that are distinct from genes where only one of the proteins is found, sug-
gesting that the two proteins can function cooperatively in certain chromatin contexts. Consistent with this, siRNA-mediated deple-
tion of Sin3 specifically reduced E2F4 levels at genes bound by both proteins; depletion of a cofactor required for binding of E2F4 to
DNA also disrupted Sin3 levels at the same genes. The authors further found that retinoblastoma binding protein 2 (RBP2) associates
with Sin3 at these genes in a complex that possesses histone deacetylase and demethylase activities. Relative to proliferating my-
oblasts, differentiated myotubes displayed decreased histone H3 acetylation (H3Ac) and lysine 4 trimethylation (H3K4me3) in the
regions of Sin3/E2F4 association, indicating a likely mechanism for how these proteins direct gene repression. Indeed, this pattern
of histone modifications, which are associated with an increased nucleosome density in the region, was only observed at genes
bound by both Sin3 and E2F4 and was disrupted by depletion of either protein. Furthermore, siRNA-mediated depletion of Sin3
in differentiated myotubes resulted in derepression of those genes bound by both E2F4 and Sin3. Thus, Sin3 ensures the transcrip-
tional repression of cell-cycle genes during the differentiation of muscle cells through the direct modulation of chromatin structure.
C. van Oevelen et al. (2008). Mol. Cell 32, 359–370.
Passing on the Histone Mark
Posttranslational modifications of histone tails provide epigenetic marks on histones, thereby dictating chromatin structure. In new
work, Hansen et al. (2008) present findings that suggest a model for how trimethylation of histone H3 lysine 27 (H3K27me3), a tran-
scriptionally repressive mark, is transmitted and maintained during cell division. H3K27me3 is catalyzed by EZH2, a component of
the core Polycomb Repressive Complex 2 (PRC2), which also includes the proteins SUZ12 and EED. The authors observed that
EZH2 associates with sites of DNA replication, as determined by immunofluorescence in BrdU-labeled human diploid fibroblasts
in S phase, and the H3K27me3 histone mark during G1 of the cell cycle. Remarkably, PRC2 specifically binds to the methylation
mark it catalyzes, suggesting that the H3K27me3mark may be propagated to newly assembled nucleosomes in chromatin following
DNA replication through this interaction. Indeed, it is known that expression of the PRC2 components is induced at the beginning of S
phase. In vitro peptide-binding experiments revealed that all three of the PRC2 protein components are required for efficient asso-
ciation of the complex with histone peptides bearing the H3K27me3 mark. A reporter system in cultured cells where PRC2 can be
transiently induced and specifically targeted to the promoter of a stably integrated luciferase reporter gene further showed that once
the H3K27me3 mark is established at the reporter gene promoter, it is maintained through multiple cell cycles, as evidenced by the
continued repression of the reporter gene in a manner that requires the catalytic domain of EZH2. As ‘‘old’’ histones assemble with
newly synthesized histones in chromatin following the progression of a replication fork, these data provide evidence for the specific
targeting of PRC2 activity by ‘‘old’’ H3K27me3 marks to new histones within a nucleosome for the maintenance of the modification.
K.H. Hansen et al. (2008). Nat. Cell Biol. 10, 1291–1300.
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